1. Home
  2. MKZR vs AIDX Comparison

MKZR vs AIDX Comparison

Compare MKZR & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MacKenzie Realty Capital Inc.

MKZR

MacKenzie Realty Capital Inc.

N/A

Current Price

$1.03

Market Cap

2.9M

Sector

N/A

ML Signal

N/A

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

N/A

Current Price

$0.18

Market Cap

2.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MKZR
AIDX
Founded
2012
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
2.9M
IPO Year
2012
2025

Fundamental Metrics

Financial Performance
Metric
MKZR
AIDX
Price
$1.03
$0.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.4K
★ 206.0K
Earning Date
12-01-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.87
34.48
EPS
N/A
★ N/A
Revenue
★ $20,007,414.00
$2,045,133.00
Revenue This Year
N/A
$44.20
Revenue Next Year
N/A
$95.73
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 16.71
52 Week Low
$0.83
$0.18
52 Week High
$5.22
$18.96

Technical Indicators

Market Signals
Indicator
MKZR
AIDX
Relative Strength Index (RSI) 49.55 30.30
Support Level $1.01 N/A
Resistance Level $1.23 $0.27
Average True Range (ATR) 0.13 0.03
MACD 0.02 0.00
Stochastic Oscillator 60.89 0.00

Price Performance

Historical Comparison
MKZR
AIDX

About MKZR MacKenzie Realty Capital Inc.

Mackenzie Realty Capital Inc is a real estate investment manager and a real estate investment trust (REIT) engaged in discounted real estate securities and asset management. The Company operates through two primary operating and reportable segments: commercial, which generates maximum revenue, and residential. These segments include activities related to acquiring, owning, developing, and managing income-producing real estate properties. Its properties are geographically diversified throughout the United States.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: